These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 27378042)
1. In Reply II-Risk of Disseminated Disease in Immunocompromised Patients Receiving Live Zoster Vaccine. Cheetham TC Mayo Clin Proc; 2016 Jul; 91(7):971-2. PubMed ID: 27378042 [No Abstract] [Full Text] [Related]
2. In Reply I-Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine. Bubb MR Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378041 [No Abstract] [Full Text] [Related]
3. Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine. Young EJ Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378040 [No Abstract] [Full Text] [Related]
4. In reply--Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination. Cheetham TC; Sy LS; Jacobsen SJ Mayo Clin Proc; 2015 Nov; 90(11):1586-7. PubMed ID: 26541255 [No Abstract] [Full Text] [Related]
5. Herpes zoster in people who are immunocompromised: what are the options for prevention? Warren-Gash C; Breuer J Lancet Infect Dis; 2019 Sep; 19(9):922-924. PubMed ID: 31399376 [No Abstract] [Full Text] [Related]
6. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682 [TBL] [Abstract][Full Text] [Related]
7. Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination. Bubb MR Mayo Clin Proc; 2015 Nov; 90(11):1585-6. PubMed ID: 26541254 [No Abstract] [Full Text] [Related]
8. Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine. Kim DH Cornea; 2019 Feb; 38(2):e5. PubMed ID: 30431474 [No Abstract] [Full Text] [Related]
9. Disseminated varicella zoster virus in an immunized child as the acquired immunodeficiency syndrome-defining illness. Chilek K; Routhouska S; Tamburro J Pediatr Dermatol; 2010; 27(2):192-4. PubMed ID: 19686302 [TBL] [Abstract][Full Text] [Related]
10. Zoster vaccine: current status and future prospects. Oxman MN Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454 [TBL] [Abstract][Full Text] [Related]
11. In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years. Sacks HS Ann Intern Med; 2017 Jan; 166(2):JC5. PubMed ID: 28114461 [No Abstract] [Full Text] [Related]
12. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711 [TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine brings relief for the elderly. Morrow T Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848 [No Abstract] [Full Text] [Related]
14. Reply to Dunning. Gilbert PB; Gabriel EE; Hudgens MG; Miao X; Li X; Su SC; Parrino J; Chan IS J Infect Dis; 2015 Nov; 212(9):1521-3. PubMed ID: 25985906 [No Abstract] [Full Text] [Related]
15. Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination. Cheetham TC; Marcy SM; Tseng HF; Sy LS; Liu IL; Bixler F; Baxter R; Donahue JG; Naleway AL; Jacobsen SJ Mayo Clin Proc; 2015 Jul; 90(7):865-73. PubMed ID: 26051268 [TBL] [Abstract][Full Text] [Related]
16. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster. Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934 [TBL] [Abstract][Full Text] [Related]